The association between plasma omega-3 fatty acids and suicidal ideation/self-harm in the United Kingdom Biobank
Lipids in Health and Disease
Franco et al. Lipids in Health and Disease
(2025) 24:364
https://doi.org/10.1186/s12944-025-02689-1
Open Access
RESEARCH
The association between plasma omega-3
fatty acids and suicidal ideation/self-harm
in the United Kingdom Biobank
W. Grant Franco1, Nathan L. Tintle2,3, Jason Westra2, Evan L. O’Keefe1, James H. O’Keefe1 and William S. Harris2,4*
Abstract
Background Self-harm is a significant public health concern, with increasing prevalence globally. Omega-3 fatty
acids (FAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known for their health
benefits, including potential mental health improvements. This study explores the association between omega-3 FAs
and self-harm behaviors using data from the UK Biobank (UKBB).
Objectives To investigate the relationship between plasma levels of omega-3 FAs and various measures of self-harm,
including passive suicidal ideation and deliberate self-harm, within a large cohort study.
Methods This observational study analyzed data from a random subset of 258,012 participants with plasma omega-3
FA levels, covariate data, and self-harm records. Omega-3 levels were measured using Nuclear Magnetic Resonance
(NMR) and are expressed as a percent of total FAs. Self-harm outcomes were assessed through self-reported
questionnaires and medical records. Covariates included demographic, health, and lifestyle factors. Statistical analyses
involved logistic regression and Cox proportional hazards models, adjusting for relevant covariates. Adjusted odds
ratios (aORs) are presented and 95% confidence intervals.
Results Higher levels of DHA, non-DHA (ALA+EPA+DPA) and total omega-3 were generally inversely associated with
passive suicidal ideation, history of self-harm, and future self-harm, with both DHA and non-DHA showing some of
the strongest associations. Participants in the highest quintile of non-DHA had a 14% lower risk of passive suicidal
ideation in the last year (aOR = 0.86; 95% CI 0.75, 0.99), and the highest DHA levels were associated with a 33% lower
odds of history of self-harm (aOR = 0.67; 95% CI 0.55, 0.83). These associations were generally stronger for medical
record-based outcomes than for self-reported data.
Conclusions This study provides evidence that higher omega-3 FA levels, both DHA and non-DHA, are associated
with reduced risks of self-harm and suicidal ideation. These findings suggest that omega-3 FAs may play a protective
role in mental health, highlighting the potential of dietary interventions to mitigate self-harm behaviors.
Keywords Omega-3, Self-harm, suicide, Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA)
*Correspondence:
William S. Harris
1
Saint Luke’s Mid America Heart Institute, University of Missouri-Kansas
City, Kansas City, MO, USA
2
Fatty Acid Research Institute, 4600 W. Nobel Street, Suite 123, Sioux Falls,
SD 57107, USA
3
Department of Population Health Nursing Science, College of Nursing,
University of Illinois – Chicago, Chicago, IL, USA
4
Department of Internal Medicine, Sanford School of Medicine, University
of South Dakota, Sioux Falls, SD, USA
© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0
International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you
give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the
licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or
exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creati
vecommons.org/licenses/by-nc-nd/4.0/.
Franco et al. Lipids in Health and Disease
(2025) 24:364
Introduction
The prevalence of self-harm, a significant public health
concern globally, has increased over recent years. A
recent report from England showed a two-fold increase
in reported self-harm from 2.4% prevalence to 6.4%
between 2000 and 2012 with a particularly notable
increase among females aged 16–24 years, where prevalence jumped from 6.5 to 19.7% [1]. Deliberate self-harm,
which includes non-suicidal self-injury involves behaviors such as cutting, burning, or self-poisoning and is
often a manifestation of psychological distress [2–4].
Studies have reported varying rates of self-harm across
different populations, with lifetime prevalence of this
form of self-harm of 22% [5–8]. These findings underscore the urgency of addressing self-harm and its underlying causes to mitigate its impact on individuals and
society.
Omega-3 fatty acids (FAs), in particular eicosapentaenoic (EPA) and docosahexaenoic acids (DHA), are
bioactive constituents of certain fish and seafoods and
have well-documented health benefits. These include
protective effects against cardiovascular disease (CVD)
and cognitive decline [9]. Recent evidence suggests that
omega-3 FAs may also offer significant mental health
benefits, potentially reducing the risk of depression, and
anxiety, and possibly influencing self-harm behaviors
[10]. The etiology of these benefits is believed to be linked
to the anti-inflammatory properties of these FAs and to
their crucial role in brain function [11]. Specifically, EPA
and DHA are integral to maintaining neuronal cell membrane fluidity and function, which in turn supports neurotransmission and may mitigate mood disorders [12].
Supporting evidence for the impact of omega-3 FAs on
mental health is growing, with studies linking higher levels of these nutrients to reduced symptoms of depression
and anxiety [13–15]. For instance, the Women’s Health
Initiative Memory Study found that higher omega-3
index levels (erythrocyte EPA+DHA) were associated
with significantly lower risks of major depressive disorder
(MDD) and other psychiatric conditions [16]. A recent
report from the National Health And Nutrition Examination Survey found that higher intakes of omega-3
FAs (and of the omega-6 FA, linoleic acid) were linked
to lower rates of suicidal ideation [17]. Plasma levels of
omega-3 FAs were lower in US service personnel who
ultimately committed suicide than in controls [18]. However, a study among individuals admitted to Emergency
Department for attempted (or planned) suicide did not
find an association with lower plasma omega-3 levels,
but with lower arachidonic acid levels (another omega-6
FA) [19]. Beyond these observational studies, omega-3
supplementation has shown promise in reducing the
s (...truncated)